Home Cart 0 Sign in  

[ CAS No. 930785-40-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 930785-40-3
Chemical Structure| 930785-40-3
Structure of 930785-40-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 930785-40-3 ]

Related Doc. of [ 930785-40-3 ]

Alternatived Products of [ 930785-40-3 ]
Product Citations

Product Details of [ 930785-40-3 ]

CAS No. :930785-40-3 MDL No. :MFCD11227065
Formula : C13H24N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :FRROFBJYHIEDPS-UHFFFAOYSA-N
M.W : 256.34 Pubchem ID :53302318
Synonyms :

Calculated chemistry of [ 930785-40-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.92
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 76.74
TPSA : 50.8 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.0
Log Po/w (XLOGP3) : 0.68
Log Po/w (WLOGP) : 0.61
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 1.21
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.66
Solubility : 5.61 mg/ml ; 0.0219 mol/l
Class : Very soluble
Log S (Ali) : -1.32
Solubility : 12.2 mg/ml ; 0.0475 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.12
Solubility : 1.95 mg/ml ; 0.0076 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.12

Safety of [ 930785-40-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 930785-40-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 930785-40-3 ]
  • Downstream synthetic route of [ 930785-40-3 ]

[ 930785-40-3 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 1160247-07-3 ]
  • [ 930785-40-3 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 25 - 70℃; for 16 h;
Stage #2: With N,N`-dimethylethylenediamine In methanol at 70℃; for 16 h;
This reaction was carried out in 12 batches, as follows. Borane-dimethyl sulfide complex (10 M in dimethyl sulfide, 75 mL, 750 mmol) was added in a drop-wise manner to a solution of C22 (50 g, 180 mmol) in tetrahydrofuran (1.5 L). The reaction mixture was heated at reflux (70 °C) for 6 hours and subsequently allowed to stir at 25 °C for 10 hours. It was then quenched with methanol (500 mL), stirred for 30 minutes at 25 °C, and concentrated under reduced pressure. The resulting white solid was dissolved in methanol (1 L), treated with Ν,Ν'- dimethylethane-1 ,2-diamine (65 g, 740 mmol), and heated at reflux (70 °C) for 16 hours. The 12 reaction mixtures were combined and concentrated in vacuo to provide a light yellow oil; this was dissolved in dichloromethane (4 L), washed with aqueous ammonium chloride solution (4 x 2 L), dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was triturated with petroleum ether (500 mL) at 25 °C for 30 minutes to provide the product (304 g) as a white solid. The filtrate from the trituration was concentrated in vacuo, and the residue was triturated with petroleum ether (200 mL) at 25 °C for 36 hours, affording additional product (135 g) as a white solid. Combined yield: 439 g, 1.71 mol, 77percent. LCMS m/z 257.2 [M+H]+. 1 H NMR (400 MHz, CDCI3) δ 3.85-3.59 (m, 4H), 3.14 (br dd, J=1 1 , 1 1 Hz, 2H), 2.84 (dd, J=4.9, 4.6 Hz, 2H), 2.68 (s, 2H), 2.02-1.84 (br m, 2H), 1.47-1.33 (m, 2H), 1.45 (s, 9H).
77%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 25 - 70℃; for 16 h;
Stage #2: With N,N`-dimethylethylenediamine In tetrahydrofuran; methanol at 70℃; for 16 h;
This reaction was carried out in 12 batches, asfollows. Borane-dimethyl sulfide complex (10 M in dimethylsulfide, 75 mL, 750 mmol) was added in a drop-wisemanner to a solution of C2 (50 g, 180 mmol) in tetrahydrofuran(1.5 L). The reaction mixture was heated at reflux (70°C.) for 6 hours and subsequently allowed to stir at 25° C. for10 hours. It was then quenched with methanol (500 mL),stirred for 30 minutes at 25° C., and concentrated underreduced pressure. The resulting white solid was dissolved inmethanol (1 L), treated with N,N'-dimethylethane-1,2-diamine(65 g, 740 mmol), and heated at reflux (70° C.) for 16hours. The 12 reaction mixtures were combined and concentratedin vacuo to provide a light yellow oil; this wasdissolved in dichloromethane (4 L), washed with aqueousammonium chloride solution (4x2 L), dried over sodiumsulfate, filtered, and concentrated under reduced pressure.The residue was triturated with petroleum ether (500 mL) at25° C. for 30 minutes to provide the product (304 g) as awhite solid. The filtrate from the trituration was concentratedin vacuo, and the residue was triturated with petroleum ether(200 mL) at 25° C. for 36 hours, affording additional product(135 g) as a white solid. Combined yield: 439 g, 1.71 mol,77percent. LCMS m/z 257.2 [M+Ht. 1H NMR (400 MHz,CDC13 ) o 3.85-3.59 (m, 4H), 3.14 (br dd, 1=11, 11 Hz, 2H),2.84 (dd, 1=4.9, 4.6 Hz, 2H), 2.68 (s, 2H), 2.02-1.84 (br m,2H), 1.47-1.33 (m, 2H), 1.45 (s, 9H).
65%
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 55℃; for 2 h;
Stage #2: With N,N`-dimethylethylenediamine In methanolReflux
Intermediate 9A: tert-butyl I -oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate To a solution of intermediate 3G (1.50 g, 5.55 mmol) in THE (19 mL), borane-dimethyl sulfide complex (1.67 mL, 16.6 mmol) was added dropwise at r.t.. The reactionmixture was stirred at 55 00 for 2 h, then it was cooled to r.t.. MeOH was added dropwise and the solvent was concentrated under vacuum. The obtained residue was dissolved in methanol (20 mL), N,W-dimethylethylenediamine (3.0 mL, 28.3 mmol) was added and the mixture was stirred under reflux overnight. After cooling to r.t., the volatiles were removed under vacuum, and the residue was purified by flashchromatography, silica gel, gradient dichloromethane to methanol:dichloromethane (1:4) to give the title compound (0.928 g, 65percent yield). HPLC retention time: 2.91 mm; MS: 257 (M+H).
0.928 g
Stage #1: With dimethylsulfide borane complex In tetrahydrofuran at 55℃; for 2 h;
Stage #2: With N,N`-dimethylethylenediamine In methanolReflux
To a solution of intermediate 3A (1.50 g, 5.55 mmol) in THF (19 mL), borane-dimethyl sulfide complex (1.67 mL, 16.6 mmol) was added dropwise at r.t. The reaction mixture was stirred at 55 °C for 2 h, then it was cooled to r.t.. MeOH was carefully added and the solvent was concentrated under vacuum. The residue was dissolved in methanol (20 mL), A/.A/'-dimethylethylenediamine (3.0 mL, 28.3 mmol) was added and the mixture was stirred under reflux overnight. After cooling to r.t., the volatiles were removed under vacuum, and the residue was purified by flash chromatography, silica gel, gradient dichloromethane to methanokdichloromethane (1 :4) to give the title compound (0.928 g, 65percent yield). HPLC retention time: 2.91 min; MS: 257 (M+H).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 24, p. 7458 - 7461
[2] Patent: WO2017/21805, 2017, A1, . Location in patent: Page/Page column 83; 85
[3] Patent: US2018/208608, 2018, A1, . Location in patent: Paragraph 0243; 0244; 0246
[4] Patent: WO2015/185207, 2015, A1, . Location in patent: Page/Page column 190; 191
[5] Patent: WO2015/185208, 2015, A1, . Location in patent: Page/Page column 147; 148
[6] Patent: WO2016/65582, 2016, A1, . Location in patent: Page/Page column 49
[7] Patent: WO2016/122994, 2016, A1, . Location in patent: Page/Page column 47
  • 2
  • [ 392331-66-7 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2015/185207, 2015, A1,
[2] Patent: WO2015/185208, 2015, A1,
[3] Patent: WO2016/65582, 2016, A1,
[4] Patent: WO2016/122994, 2016, A1,
[5] Patent: WO2017/21805, 2017, A1,
[6] Patent: US2018/208608, 2018, A1,
  • 3
  • [ 147804-30-6 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2015/185207, 2015, A1,
[2] Patent: WO2015/185208, 2015, A1,
  • 4
  • [ 79099-07-3 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2016/65582, 2016, A1,
[2] Patent: WO2016/122994, 2016, A1,
  • 5
  • [ 819800-93-6 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2016/65582, 2016, A1,
[2] Patent: WO2016/122994, 2016, A1,
  • 6
  • [ 41661-47-6 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2016/65582, 2016, A1,
[2] Patent: WO2016/122994, 2016, A1,
  • 7
  • [ 24424-99-5 ]
  • [ 930785-40-3 ]
Reference: [1] Patent: WO2016/65582, 2016, A1,
[2] Patent: WO2016/122994, 2016, A1,
Recommend Products
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 930785-40-3 ]

Amides

Chemical Structure| 169206-55-7

[ 169206-55-7 ]

tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate

Similarity: 0.96

Chemical Structure| 340962-93-8

[ 340962-93-8 ]

1-Boc-4-Morpholin-4-ylmethyl-piperidine

Similarity: 0.93

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 161157-50-2

[ 161157-50-2 ]

tert-Butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate

Similarity: 0.91

Chemical Structure| 392331-66-7

[ 392331-66-7 ]

1-Boc-4-(Aminomethyl)-4-hydroxypiperidine

Similarity: 0.91

Related Parent Nucleus of
[ 930785-40-3 ]

Aliphatic Heterocycles

Chemical Structure| 169206-55-7

[ 169206-55-7 ]

tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate

Similarity: 0.96

Chemical Structure| 340962-93-8

[ 340962-93-8 ]

1-Boc-4-Morpholin-4-ylmethyl-piperidine

Similarity: 0.93

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 161157-50-2

[ 161157-50-2 ]

tert-Butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate

Similarity: 0.91

Chemical Structure| 392331-66-7

[ 392331-66-7 ]

1-Boc-4-(Aminomethyl)-4-hydroxypiperidine

Similarity: 0.91

Morpholines

Chemical Structure| 340962-93-8

[ 340962-93-8 ]

1-Boc-4-Morpholin-4-ylmethyl-piperidine

Similarity: 0.93

Chemical Structure| 136992-21-7

[ 136992-21-7 ]

(R)-tert-Butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate

Similarity: 0.88

Chemical Structure| 1824327-48-1

[ 1824327-48-1 ]

tert-Butyl 2-(1-aminoethyl)morpholine-4-carboxylate

Similarity: 0.86

Chemical Structure| 864369-95-9

[ 864369-95-9 ]

tert-Butyl 4-methyl-4-morpholinopiperidine-1-carboxylate

Similarity: 0.85

Chemical Structure| 135065-76-8

[ 135065-76-8 ]

(S)-tert-Butyl 2-(hydroxymethyl)morpholine-4-carboxylate

Similarity: 0.82

Piperidines

Chemical Structure| 169206-55-7

[ 169206-55-7 ]

tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate

Similarity: 0.96

Chemical Structure| 340962-93-8

[ 340962-93-8 ]

1-Boc-4-Morpholin-4-ylmethyl-piperidine

Similarity: 0.93

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 392331-66-7

[ 392331-66-7 ]

1-Boc-4-(Aminomethyl)-4-hydroxypiperidine

Similarity: 0.91

Chemical Structure| 143900-44-1

[ 143900-44-1 ]

(S)-tert-Butyl 3-hydroxypiperidine-1-carboxylate

Similarity: 0.86

Spiroes

Chemical Structure| 169206-55-7

[ 169206-55-7 ]

tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate

Similarity: 0.96

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 301226-25-5

[ 301226-25-5 ]

tert-Butyl 1-oxa-5-azaspiro[2.4]heptane-5-carboxylate

Similarity: 0.86

Chemical Structure| 1209319-87-8

[ 1209319-87-8 ]

tert-Butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate

Similarity: 0.86

Chemical Structure| 189333-03-7

[ 189333-03-7 ]

tert-Butyl 2,9-diazaspiro[5.5]undecane-2-carboxylate

Similarity: 0.84